REG - European Opps. Trust - Portfolio Update
RNS Number : 9694NEuropean Opportunities Trust PLC04 October 2021EUROPEAN OPPORTUNITIES TRUST PLC
Legal Entity Identifier: 549300XN7RXQWHN18849
Month end portfolio information as at 30 September 2021
Total Net Assets: £ 960,603,063
Total Assets (including drawdown bank debt): £ 1,035,603,063
Top twenty holdings
Stock
Sector
Country of Listing
% of Total Assets (Incl Drawn down bank debt)
Experian Plc
Industrials
United Kingdom
9.8
Novo Nordisk A/S-B
Health Care
Denmark
9.7
Dassault Systemes SE
Information Technology
France
8.5
Relx Plc
Industrials
Netherlands
8.1
Genus Plc
Health Care
United Kingdom
7.7
Intermediate Capital Group
Financials
United Kingdom
5.6
Grifols SA
Health Care
Spain
4.7
Biomerieux
Health Care
France
4.7
Deutsche Boerse AG
Financials
Germany
4.5
Infineon Technologies AG
Information Technology
Germany
3.9
S.O.I.T.E.C.
Information Technology
France
3.5
Edenred
Information Technology
France
3.3
ASML Holding NV
Information Technology
Netherlands
2.7
Darktrace Plc
Information Technology
United Kingdom
2.6
Ubisoft Entertainment
Communication Services
France
2.3
Gaztransport et Techniga SA
Energy
France
1.8
Barry Callebaut AG-Reg
Consumer Staples
Switzerland
1.7
Bayer AG-Reg
Health Care
Germany
1.5
Merck KGAA
Health Care
Germany
1.4
Neste OYJ
Energy
Finland
1.3
Country of listing of investee companies
Country
% of Total assets (including drawn down bank debt)
United Kingdom
28.2
France
24.8
Germany
13.7
Netherlands
11.5
Denmark
9.7
Spain
4.7
Switzerland
1.7
Norway
1.5
Finland
1.3
Cash/(Gearing)
2.8
Market Capitalisation of investee companies
Market Cap
% of Total Assets (including Drawn down bank debt)
Large
83.6
Mid
13.3
Small
0.3
Cash/(Gearing)
2.8
The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com
Enquiries:
Devon Equity Management Limited,
Company Secretaries to European Opportunities Trust PLC
Richard Pavry
020 3985 0441
4 October 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDPFUBLBDGLBGDGBS
Recent news on Barry Callebaut AG
See all newsREG - UBS AG - Post Stabilisation Notice Barry Callebaut EUR
AnnouncementREG - Stock Exch Notice - Admission to ISM - 06/03/2025
AnnouncementREG - UBS AG - Pre Stabilisation Notice - Barry Callebaut EUR
AnnouncementREG - European Opps. Trust - Portfolio Update
AnnouncementREG - European Opps. Trust - Portfolio Update
Announcement